Corrigendum to "Safety and feasibility of CDK4/6 inhibitors treatment combined with radiotherapy in patients with HR-positive/HER2-negative breast cancer. A systematic review and meta-analysis" [Radiother. Oncol. 187 (2023) 109839]
Radiother Oncol. 2024 May:194:110188.
doi: 10.1016/j.radonc.2024.110188.
Epub 2024 Mar 6.
1 Breast Cancer Center, Maria Sklodowska-Curie National Research Institute of Oncology Gliwice Branch, Poland. Electronic address: marcin.kubeczko@io.gliwice.pl.
2 Breast Cancer Center, Maria Sklodowska-Curie National Research Institute of Oncology Gliwice Branch, Poland.
3 Department of Radiotherapy, Maria Sklodowska-Curie National Research Institute of Oncology Gliwice Branch, Poland.
4 Department of Biostatistics and Bioinformatics, Maria Sklodowska-Curie National Research Institute of Oncology Gliwice Branch, Poland.
5 Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York City, USA.